Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: A case report

Journal of Medical Case Reports

Volumn 4, Issue , 2010, Pages

  Baune, Bernhard T ^a   Eyre, Harris ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; C REACTIVE PROTEIN; CODEINE; ESCITALOPRAM; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; MIRTAZAPINE; OXYCODONE; PARACETAMOL; PAROXETINE; QUETIAPINE; RISPERIDONE; SALAZOSULFAPYRIDINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANXIETY; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMOTIONAL DISORDER; FEMALE; FRUSTRATION; HUMAN; MAJOR DEPRESSION; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; VISUAL ANALOG SCALE;

EID: 77049107747     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-4-6     Document Type: Article

References (18)

1. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. KR Merikangas A Kalaydjian, Curr Opin Psychiatr 2007 20 4 353 358 10.1097/YCO.0b013e3281c61dc5 (Pubitemid 46889662)
2. Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy. RC Kaplan WH Frishman, Heart Dis 2001 3 5 326 332 10.1097/00132580-200109000-00009 11975814
3. Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis. X Wu F Shih JP Atkinson, Arthritis Rheum 2007 56 9 2823 2828 10.1002/art.22858 17763409
4. From inflammation to sickness and depression: when the immune system subjugates the brain. R Dantzer JC O'Connor GG Freund RW Johnson KW Kelley, Nat Reviews Neurosci 2008 9 1 46 56 10.1038/nrn2297 (Pubitemid 350295688)
5. Pharmacogenomics of neuroimmune interactions in human psychiatric disorders. J Licinio C Mastronardi ML Wong, Exp Physiol 2007 92 5 807 811 10.1113/expphysiol.2007.038471 17675415
6. New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. BT Baune, Neuropsychiatr Dis Treat 2008 4 6 1181 1191 19337458
7. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. C Dickens L McGowan D Clark-Carter F Creed, Psychosom Med 2002 64 1 52 60 11818586
8. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. TO Bruce, Curr Psychiatry Rep 2008 10 3 258 264 10.1007/s11920-008-0042-1 18652795
9. Antidepressant therapy and C-reactive protein levels. SM O'Brien LV Scott TG Dinan, Br J Psychiatry 2006 188 449 452 10.1192/bjp.bp.105.011015 16648531
10. Antidepressant drugs and experimental inflammation. M Bianchi AE Panerai, Pharmacol Res 1996 33 4-5 235 238 10.1006/phrs.1996.0032 8938014
11. Mechanism of inhibition of experimental inflammation by antidepressant drugs. EA Martelli E Toth AD Segre N Corsico, Eur J Pharmacol 1967 2 3 229 233 5590348
12. Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. M Taler M Bar I Korob L Lomnitski E Baharav N Grunbaum-Novak A Weizman I Gil-Ad, Int Immunopharmacol 2008 8 4 526 533 10.1016/j.intimp.2007.12.003 18328443
13. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. T Eller V Vasar J Shlik E Maron, Prog Neuropsychopharmacol Biol Psychiatry 2008 32 2 445 450 10.1016/j.pnpbp.2007.09. 015 17976882
14. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. E Carrizo V Fernandez J Quintero L Connell Z Rodriguez M Mosquera A Acosta T Baptista, Schizophr Res 2008 103 1-3 83 93 10.1016/j.schres.2008.03.004 18436434
15. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. X Fan C Pristach EY Liu O Freudenreich DC Henderson DC Goff, Psychiatry Res 2007 149 1-3 267 271 10.1016/j.psychres.2006.07.011 17112596
16. Effects of antipsychotic drugs on cytokine networks. T Pollmacher M Haack A Schuld T Kraus D Hinze-Selch, J Psychiatr Res 2000 34 6 369 382 10.1016/S0022-3956(00)00032-7 11165304
17. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. AC Altamura F Boin M Maes, Eur Neuropsychopharmacol 1999 10 1 1 4 10.1016/S0924-977X(99)00017-6 10647089
18. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. H Sugino T Futamura Y Mitsumoto K Maeda Y Marunaka, Prog Neuropsychopharmacol Biol Psychiatry 2009 33 2 303 307 10.1016/j.pnpbp.2008.12.006 19138716